Literature DB >> 18283246

Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy.

Monika Klirova1, Tomas Novak, Miloslav Kopecek, Pavel Mohr, V Strunzova.   

Abstract

Sir: For women diagnosed with Recurrent depressive disorder, pregnancy poses a major treatment challenge. Apart from antidepressants, the most commonly used biological therapeutical method is ECT (electroconvulsive therapy). We believe that similar efficacy can be achieved using rTMS as a safer option with substantially less side effects. So far, only a few case-reports reporting the use of rTMS for treatment of pregnant patients with depression were published.

Entities:  

Mesh:

Year:  2008        PMID: 18283246

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  10 in total

1.  A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy.

Authors:  Deborah R Kim; Laura Sockol; Jacques P Barber; Marian Moseley; Lisa Lamprou; Karl Rickels; John P O'Reardon; C Neill Epperson
Journal:  J Affect Disord       Date:  2010-09-22       Impact factor: 4.839

Review 2.  Clinical trial design in non-invasive brain stimulation psychiatric research.

Authors:  André Russowsky Brunoni; Felipe Fregni
Journal:  Int J Methods Psychiatr Res       Date:  2011-06       Impact factor: 4.035

Review 3.  Pregnancy and depression: exploring a new potential treatment option.

Authors:  Deborah R Kim; Juan Gonzalez; John P O'Reardon
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 4.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

5.  Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder.

Authors:  Deborah R Kim; Eileen Wang; Brendan McGeehan; Jessica Snell; Grace Ewing; Claudia Iannelli; John P O'Reardon; Mary D Sammel; C Neill Epperson
Journal:  Brain Stimul       Date:  2018-09-14       Impact factor: 8.955

6.  Neuromodulation for treatment-resistant depression.

Authors:  Paul E Holtzheimer; Helen S Mayberg
Journal:  F1000 Med Rep       Date:  2012-11-01

Review 7.  Neuromodulation and antenatal depression: a review.

Authors:  Deborah R Kim; Jessica L Snell; Grace C Ewing; John O'Reardon
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-07       Impact factor: 2.570

8.  Repetitive transcranial magnetic stimulation for the treatment of major depression during pregnancy.

Authors:  Ygor Arzeno Ferrão; Renata de Melo Felipe da Silva
Journal:  Braz J Psychiatry       Date:  2018-06       Impact factor: 2.697

9.  Repetitive transcranial magnetic stimulation treatment for peripartum depression: systematic review & meta-analysis.

Authors:  Hyune June Lee; Sung Min Kim; Ji Yean Kwon
Journal:  BMC Pregnancy Childbirth       Date:  2021-02-09       Impact factor: 3.007

Review 10.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.